ong-Term rIsk, clinical management and healthcare Resource utilization of stable coronary artery diSease in post myocardial infarction patients. - TIGRIS

AstraZeneca AB0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•The subject population that will be observed in the NIS must fulfil all of the following criteria:
•Provision of subject informed consent
•Female and/or male aged 50 years and over
•Documented history of presumed spontaneous MI (excluding known peri-procedural or definite secondary MI [eg, due to profound hypotension, hypertensive emergency, tachycardia, or profound anemia]) with their most recent MI occurring 1 to 3 years prior to enrollment and have at least 1 of the following risk factors:
•Age . 65 years
•. Diabetes mellitus requiring medication
•. Documented history of a second prior presumed spontaneous MI ( >1 year ago)
•. Documented history of angiographic evidence of multivessel coronary artery disease (CAD)
•. Chronic, non-end stage renal dysfunction (15 mL/min . creatinine clearance, calculated by Cockcroft Gault equation, <60 mL/min)

•Patients will not be eligible to participate if any of the following exclusion criteria are present:
•Presence of any condition/circumstance which in the opinion of the investigator could significantly limit the complete follow up of the patient (e.g. tourist, non-native speaker or does not understand the local language where interpreter services are not reliably available, psychiatric disturbances, alcohol or drug abuse).
•Presence of serious/severe co-morbidities in the opinion of the investigator which may limit life expectancy ( <1 year).
•Current participation in a blinded randomized clinical trial.
•Patients receiving treatment of ticagrelor beyond 12 months or off label use of ticagrelor.

发起方